nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration
|
Soreghan, Brian |
|
2003 |
151-152 |
11 |
p. 1515-1524 10 p. |
artikel |
2 |
Actin microfilaments et al.—the many components, effectors and regulators of epithelial cell endocytosis
|
da Costa, Silvia R |
|
2003 |
151-152 |
11 |
p. 1359-1383 25 p. |
artikel |
3 |
Advanced drug delivery reviews theme issue
|
Rotello, V.M. |
|
2008 |
151-152 |
11 |
p. 1225- 1 p. |
artikel |
4 |
Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents
|
Hirsh, Andrew J |
|
2002 |
151-152 |
11 |
p. 1445-1462 18 p. |
artikel |
5 |
Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers
|
Wong, Andrew D. |
|
2012 |
151-152 |
11 |
p. 1031-1045 15 p. |
artikel |
6 |
Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets
|
Hassett, Daniel J. |
|
2002 |
151-152 |
11 |
p. 1425-1443 19 p. |
artikel |
7 |
Animal data: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo
|
Lennernäs, Hans |
|
2007 |
151-152 |
11 |
p. 1103-1120 18 p. |
artikel |
8 |
An overview of the pathogenesis of cystic fibrosis lung disease
|
Boucher, R.C |
|
2002 |
151-152 |
11 |
p. 1359-1371 13 p. |
artikel |
9 |
Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development
|
Mahmood, Iftekhar |
|
2007 |
151-152 |
11 |
p. 1177-1192 16 p. |
artikel |
10 |
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
|
Ferrari, Stefano |
|
2002 |
151-152 |
11 |
p. 1373-1393 21 p. |
artikel |
11 |
Bioconjugated quantum dots for in vivo molecular and cellular imaging
|
Smith, Andrew M. |
|
2008 |
151-152 |
11 |
p. 1226-1240 15 p. |
artikel |
12 |
Biological properties of “naked” metal nanoparticles
|
Bhattacharya, Resham |
|
2008 |
151-152 |
11 |
p. 1289-1306 18 p. |
artikel |
13 |
BioMEMS: state-of-the-art in detection, opportunities and prospects
|
Bashir, Rashid |
|
2004 |
151-152 |
11 |
p. 1565-1586 22 p. |
artikel |
14 |
Biomimetic materials and micropatterned structures using iniferters
|
Peppas, Nicholas A. |
|
2004 |
151-152 |
11 |
p. 1587-1597 11 p. |
artikel |
15 |
Bottom-up design of biomimetic assemblies
|
Tu, Raymond S. |
|
2004 |
151-152 |
11 |
p. 1537-1563 27 p. |
artikel |
16 |
Challenges and obstacles of ocular pharmacokinetics and drug delivery
|
Urtti, Arto |
|
2006 |
151-152 |
11 |
p. 1131-1135 5 p. |
artikel |
17 |
Comparison of the mucoadhesive properties of various polymers
|
Grabovac, Vjera |
|
2005 |
151-152 |
11 |
p. 1713-1723 11 p. |
artikel |
18 |
Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules
|
Hilt, J.Zachary |
|
2004 |
151-152 |
11 |
p. 1599-1620 22 p. |
artikel |
19 |
Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic
|
Arnett, Heather A. |
|
2007 |
151-152 |
11 |
p. 1084-1092 9 p. |
artikel |
20 |
Current perspectives on the cellular uptake and trafficking of riboflavin
|
Foraker, Amy B |
|
2003 |
151-152 |
11 |
p. 1467-1483 17 p. |
artikel |
21 |
Current status of gene delivery and gene therapy in lacrimal gland using viral vectors
|
Selvam, Shivaram |
|
2006 |
151-152 |
11 |
p. 1243-1257 15 p. |
artikel |
22 |
Development and applications of photo-triggered theranostic agents
|
Rai, Prakash |
|
2010 |
151-152 |
11 |
p. 1094-1124 31 p. |
artikel |
23 |
Discovery, structure and biological activities of cyclotides
|
Daly, Norelle L. |
|
2009 |
151-152 |
11 |
p. 918-930 13 p. |
artikel |
24 |
Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics
|
Mannermaa, Eliisa |
|
2006 |
151-152 |
11 |
p. 1136-1163 28 p. |
artikel |
25 |
Editorial Board
|
|
|
2009 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2010 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2003 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
28 |
Editorial Board
|
|
|
2002 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
29 |
Editorial Board
|
|
|
2006 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
30 |
Editorial Board
|
|
|
2004 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
31 |
Editorial Board
|
|
|
2008 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
32 |
Editorial Board
|
|
|
2005 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
33 |
Editorial Board
|
|
|
2007 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
34 |
Editorial Board
|
|
|
2012 |
151-152 |
11 |
p. ii- 1 p. |
artikel |
35 |
Endocytosis and sorting of macromolecules
|
Hamm-Alvarez, Sarah F. |
|
2003 |
151-152 |
11 |
p. 1351-1352 2 p. |
artikel |
36 |
Endocytosis of adenovirus and adenovirus capsid proteins
|
Medina-Kauwe, Lali K. |
|
2003 |
151-152 |
11 |
p. 1485-1496 12 p. |
artikel |
37 |
Engineering nanomedicines using stimuli-responsive biomaterials
|
Wang, Yapei |
|
2012 |
151-152 |
11 |
p. 1021-1030 10 p. |
artikel |
38 |
Environmentally responsive peptides as anticancer drug carriers
|
Aluri, Suhaas |
|
2009 |
151-152 |
11 |
p. 940-952 13 p. |
artikel |
39 |
Enzyme-responsive nanoparticles for drug release and diagnostics
|
de la Rica, Roberto |
|
2012 |
151-152 |
11 |
p. 967-978 12 p. |
artikel |
40 |
Gold nanoparticles in delivery applications
|
Ghosh, Partha |
|
2008 |
151-152 |
11 |
p. 1307-1315 9 p. |
artikel |
41 |
Graphical Abstracts Contents Listing
|
|
|
2010 |
151-152 |
11 |
p. e1-e3 nvt p. |
artikel |
42 |
Guide to Authors
|
|
|
2003 |
151-152 |
11 |
p. 1525-1528 4 p. |
artikel |
43 |
Guide to Authors
|
|
|
2002 |
151-152 |
11 |
p. 1529-1531 3 p. |
artikel |
44 |
Guide to Authors
|
|
|
2004 |
151-152 |
11 |
p. 1689-1692 4 p. |
artikel |
45 |
Guide to Authors
|
|
|
2005 |
151-152 |
11 |
p. 1724-1729 6 p. |
artikel |
46 |
Herpes simplex virion entry into and intracellular transport within mammalian cells
|
Garner, Judy A. |
|
2003 |
151-152 |
11 |
p. 1497-1513 17 p. |
artikel |
47 |
Imaging and drug delivery using theranostic nanoparticles
|
Janib, Siti M. |
|
2010 |
151-152 |
11 |
p. 1052-1063 12 p. |
artikel |
48 |
Imaging of cellular therapies
|
Srinivas, M. |
|
2010 |
151-152 |
11 |
p. 1080-1093 14 p. |
artikel |
49 |
Industrial perspective in ocular drug delivery
|
Ali, Yusuf |
|
2006 |
151-152 |
11 |
p. 1258-1268 11 p. |
artikel |
50 |
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
|
Kellerman, Don |
|
2002 |
151-152 |
11 |
p. 1463-1474 12 p. |
artikel |
51 |
Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery
|
Peppas, Nicholas A. |
|
2004 |
151-152 |
11 |
p. 1529-1531 3 p. |
artikel |
52 |
Intraocular implants for extended drug delivery: Therapeutic applications
|
Bourges, J.L. |
|
2006 |
151-152 |
11 |
p. 1182-1202 21 p. |
artikel |
53 |
In vivo animal models for drug delivery across the lung mucosal barrier
|
Cryan, Sally-Ann |
|
2007 |
151-152 |
11 |
p. 1133-1151 19 p. |
artikel |
54 |
Magnetic nanoparticles in MR imaging and drug delivery
|
Sun, Conroy |
|
2008 |
151-152 |
11 |
p. 1252-1265 14 p. |
artikel |
55 |
Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery
|
Widera, A |
|
2003 |
151-152 |
11 |
p. 1439-1466 28 p. |
artikel |
56 |
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
|
Slowing, Igor I. |
|
2008 |
151-152 |
11 |
p. 1278-1288 11 p. |
artikel |
57 |
Micro and nano-fabrication of biodegradable polymers for drug delivery
|
Lu, Y. |
|
2004 |
151-152 |
11 |
p. 1621-1633 13 p. |
artikel |
58 |
Mouse models of inflammatory bowel disease
|
Wirtz, Stefan |
|
2007 |
151-152 |
11 |
p. 1073-1083 11 p. |
artikel |
59 |
Mucoadhesive polymers: strategies, achievements and future challenges
|
Bernkop-Schnürch, Andreas |
|
2005 |
151-152 |
11 |
p. 1553-1555 3 p. |
artikel |
60 |
Multifunctional agents for concurrent imaging and therapy in cardiovascular disease
|
McCarthy, Jason R. |
|
2010 |
151-152 |
11 |
p. 1023-1030 8 p. |
artikel |
61 |
Multifunctional magnetic nanoparticles for targeted imaging and therapy
|
McCarthy, Jason R. |
|
2008 |
151-152 |
11 |
p. 1241-1251 11 p. |
artikel |
62 |
Nanoparticle and targeted systems for cancer therapy
|
Brannon-Peppas, Lisa |
|
2004 |
151-152 |
11 |
p. 1649-1659 11 p. |
artikel |
63 |
Nanoparticle-based theranostic agents
|
Xie, Jin |
|
2010 |
151-152 |
11 |
p. 1064-1079 16 p. |
artikel |
64 |
Nanoporous microsystems for islet cell replacement
|
Desai, Tejal A. |
|
2004 |
151-152 |
11 |
p. 1661-1673 13 p. |
artikel |
65 |
Nanoscale technology of mucoadhesive interactions
|
Peppas, Nicholas A. |
|
2004 |
151-152 |
11 |
p. 1675-1687 13 p. |
artikel |
66 |
Nanotechnology and biomimetic methods in therapeutics: molecular scale control with some help from nature
|
Hilt, J. Zachary |
|
2004 |
151-152 |
11 |
p. 1533-1536 4 p. |
artikel |
67 |
Nanotechnology: challenging the limit of creativity in targeted drug delivery
|
Lee, Vincent H.L. |
|
2004 |
151-152 |
11 |
p. 1527-1528 2 p. |
artikel |
68 |
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
|
Ugwoke, Michael I. |
|
2005 |
151-152 |
11 |
p. 1640-1665 26 p. |
artikel |
69 |
Non-viral ocular gene therapy: Potential ocular therapeutic avenues
|
Bloquel, C. |
|
2006 |
151-152 |
11 |
p. 1224-1242 19 p. |
artikel |
70 |
Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems
|
Takeuchi, Hirofumi |
|
2005 |
151-152 |
11 |
p. 1583-1594 12 p. |
artikel |
71 |
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
|
Fattal, Elias |
|
2006 |
151-152 |
11 |
p. 1203-1223 21 p. |
artikel |
72 |
Ocular drug delivery
|
Urtti, Arto |
|
2006 |
151-152 |
11 |
p. 1129-1130 2 p. |
artikel |
73 |
Optimizing the future for biotechnology therapies, the key role of protein engineering
|
Camarero, Julio A. |
|
2009 |
151-152 |
11 |
p. 897-898 2 p. |
artikel |
74 |
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
|
Garcia-Contreras, Lucila |
|
2002 |
151-152 |
11 |
p. 1491-1504 14 p. |
artikel |
75 |
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
|
Konstan, Michael W. |
|
2002 |
151-152 |
11 |
p. 1409-1423 15 p. |
artikel |
76 |
Pharmacological approaches to discovery and development of new mucolytic agents
|
King, Malcolm |
|
2002 |
151-152 |
11 |
p. 1475-1490 16 p. |
artikel |
77 |
Photochemical mechanisms of light-triggered release from nanocarriers
|
Fomina, Nadezda |
|
2012 |
151-152 |
11 |
p. 1005-1020 16 p. |
artikel |
78 |
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
|
Felber, Arnaud E. |
|
2012 |
151-152 |
11 |
p. 979-992 14 p. |
artikel |
79 |
Physiology and pharmacology of the brushtail possum gastrointestinal tract: Relationship to the human gastrointestinal tract
|
McDowell, Arlene |
|
2007 |
151-152 |
11 |
p. 1121-1132 12 p. |
artikel |
80 |
Porous silicon in drug delivery devices and materials
|
Anglin, Emily J. |
|
2008 |
151-152 |
11 |
p. 1266-1277 12 p. |
artikel |
81 |
Prediction of therapeutic and drug delivery outcomes using animal models
|
Brayden, David J. |
|
2007 |
151-152 |
11 |
p. 1071-1072 2 p. |
artikel |
82 |
Preface
|
|
|
2002 |
151-152 |
11 |
p. 1357- 1 p. |
artikel |
83 |
Protein splicing: A versatile tool for drug discovery
|
Cheriyan, Manoj |
|
2009 |
151-152 |
11 |
p. 899-907 9 p. |
artikel |
84 |
Rab proteins and endocytic trafficking: potential targets for therapeutic intervention
|
Stein, Mary-Pat |
|
2003 |
151-152 |
11 |
p. 1421-1437 17 p. |
artikel |
85 |
Radionuclide probes for molecular imaging of pancreatic beta-cells
|
Wu, Zhanhong |
|
2010 |
151-152 |
11 |
p. 1125-1138 14 p. |
artikel |
86 |
Radiopharmaceutical chemistry for positron emission tomography
|
Li, Zibo |
|
2010 |
151-152 |
11 |
p. 1031-1051 21 p. |
artikel |
87 |
Recent advances in the use of cell-penetrating peptides for medical and biological applications
|
Fonseca, Sonali B. |
|
2009 |
151-152 |
11 |
p. 953-964 12 p. |
artikel |
88 |
Redox activation of metal-based prodrugs as a strategy for drug delivery
|
Graf, Nora |
|
2012 |
151-152 |
11 |
p. 993-1004 12 p. |
artikel |
89 |
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics
|
Nagata, Satoshi |
|
2009 |
151-152 |
11 |
p. 977-985 9 p. |
artikel |
90 |
Roles of the cytoskeleton and motor proteins in endocytic sorting
|
Murray, John W. |
|
2003 |
151-152 |
11 |
p. 1385-1403 19 p. |
artikel |
91 |
Sorting motifs in receptor trafficking
|
Kurten, Richard C. |
|
2003 |
151-152 |
11 |
p. 1405-1419 15 p. |
artikel |
92 |
“Splicing up” drug discovery.
|
Sancheti, Harshkumar |
|
2009 |
151-152 |
11 |
p. 908-917 10 p. |
artikel |
93 |
Stimuli-responsive drug delivery systems
|
Yang, Jerry |
|
2012 |
151-152 |
11 |
p. 965-966 2 p. |
artikel |
94 |
Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications
|
Shim, Min Suk |
|
2012 |
151-152 |
11 |
p. 1046-1059 14 p. |
artikel |
95 |
Target-specific delivery of peptide-based probes for PET imaging
|
Chen, Kai |
|
2010 |
151-152 |
11 |
p. 1005-1022 18 p. |
artikel |
96 |
T cell epitope: Friend or Foe? Immunogenicity of biologics in context
|
Weber, Constanze A. |
|
2009 |
151-152 |
11 |
p. 965-976 12 p. |
artikel |
97 |
The basics and underlying mechanisms of mucoadhesion
|
Smart, John D. |
|
2005 |
151-152 |
11 |
p. 1556-1568 13 p. |
artikel |
98 |
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems
|
Vargas, Angelica |
|
2007 |
151-152 |
11 |
p. 1162-1176 15 p. |
artikel |
99 |
The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases
|
Goss, C.H |
|
2002 |
151-152 |
11 |
p. 1505-1528 24 p. |
artikel |
100 |
The design of polyvalent scaffolds for targeted delivery
|
Vance, David |
|
2009 |
151-152 |
11 |
p. 931-939 9 p. |
artikel |
101 |
Theranostic agents that co-deliver therapeutic and imaging agents?
|
MacKay, J. Andrew |
|
2010 |
151-152 |
11 |
p. 1003-1004 2 p. |
artikel |
102 |
Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting
|
Powell, Kristina |
|
2002 |
151-152 |
11 |
p. 1395-1408 14 p. |
artikel |
103 |
The use of mucoadhesive polymers in buccal drug delivery
|
Salamat-Miller, Nazila |
|
2005 |
151-152 |
11 |
p. 1666-1691 26 p. |
artikel |
104 |
The use of mucoadhesive polymers in ocular drug delivery
|
Ludwig, Annick |
|
2005 |
151-152 |
11 |
p. 1595-1639 45 p. |
artikel |
105 |
The use of mucoadhesive polymers in vaginal delivery
|
Valenta, Claudia |
|
2005 |
151-152 |
11 |
p. 1692-1712 21 p. |
artikel |
106 |
Thiomers: A new generation of mucoadhesive polymers
|
Bernkop-Schnürch, Andreas |
|
2005 |
151-152 |
11 |
p. 1569-1582 14 p. |
artikel |
107 |
Three-dimensional tissue fabrication
|
Liu Tsang, Valerie |
|
2004 |
151-152 |
11 |
p. 1635-1647 13 p. |
artikel |
108 |
Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models
|
Godin, Biana |
|
2007 |
151-152 |
11 |
p. 1152-1161 10 p. |
artikel |
109 |
Transgenic animal models of neurodegenerative diseases and their application to treatment development
|
Rockenstein, Edward |
|
2007 |
151-152 |
11 |
p. 1093-1102 10 p. |
artikel |
110 |
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
|
Ranta, Veli-Pekka |
|
2006 |
151-152 |
11 |
p. 1164-1181 18 p. |
artikel |
111 |
Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems
|
Jones, Arwyn T. |
|
2003 |
151-152 |
11 |
p. 1353-1357 5 p. |
artikel |